Filtered By:
Specialty: Cardiology
Condition: Cardiomyopathy

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 533 results found since Jan 2013.

Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
CONCLUSIONS: An individual approach and targeted diagnostics using advanced medical technologies in selected patients, who may benefit from a tailored treatment regimen, can help reveal a probable cause in the majority of strokes and TIAs previously classified as cryptogenic.PMID:35146751 | DOI:10.1111/ane.13590
Source: Atherosclerosis - February 11, 2022 Category: Cardiology Authors: Barbara Ratajczak-Tretel Anna Tancin Lambert Dan Atar Anne Hege Aamodt Source Type: research

Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY)
ConclusionBased on a clustering analysis, three phenogroups of HCM according to the risk of AF occurrence can be identified. It can indicate which patients should be more monitored and/or treated, particular to prevent the risk of stroke.Graphic abstract
Source: Clinical Research in Cardiology - February 1, 2022 Category: Cardiology Source Type: research

Implantation of a  VDD implantable cardioverter-defibrillator lead via a persistent left superior vena cava
AbstractA  persistent left superior vena cava (LSVC) represents a challenging congenital abnormality for transvenous cardiac device implantation. In the current case a secondary prophylactic VDD implantable cardioverter-defibrillator (ICD) implantation was planned in a 75-year-old woman presenting with is chemic cardiomyopathy and elevated stroke risk. Since no venous communication to the right side was identified intraoperatively, the lead was placed via the persistent LSVC. The far-field signal on the floating atrial dipole could be successfully blanked out, and appropriate device function with hig h and stable atria...
Source: Herzschrittmachertherapie und Elektrophysiologie - January 6, 2022 Category: Cardiology Source Type: research

Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
ConclusionsHeart transplantation is a curative treatment for ARVC, but due to frequent ventricular arrhythmias and RV predominant pathology, patients require unique considerations in regard to timing of evaluation, haemodynamic support options, and wait listing qualification.
Source: ESC Heart Failure - December 25, 2021 Category: Cardiology Authors: Paul J. Scheel, Katherine Giuliano, Crystal Tichnell, Cynthia James, Brittney Murray, Harikrishna Tandri, Debra Carter, Tracey Fehr, Priya Umapathi, Joban Vaishnav, Sabra C. Lewsey, Steven Hsu, Hugh Calkins, Kavita Sharma, Chun Woo Choi, Ni Tags: Original Article Source Type: research

Non-invasive right ventriculo-arterial coupling as a rehospitalization predictor in dilated cardiomyopathy: A comparison of five different methods
CONCLUSION: RVFW-LS/PASP and RVEF/PASP as non-invasive estimates of RVPAC are independent predictors of HF rehospitalization in patients with DCM.PMID:34939658 | DOI:10.33963/KP.a2021.0190
Source: Polish Heart Journal - December 23, 2021 Category: Cardiology Authors: Aura V îjîiac Vlad B ătăilă Sebastian Onciul Violeta Verinceanu Claudia Guzu Silvia Deaconu Ioana Petre Alina Sc ărlătescu Diana Zamfir Maria Doroban ţu Source Type: research